Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    November 2021
  1. DICKER I, Jeffrey JL, Protack T, Lin Z, et al
    GSK3640254 Is a Novel HIV-1 Maturation Inhibitor With an Optimized Virology Profile.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0187621. doi: 10.1128/AAC.01876.
    PubMed     Abstract available


  2. ZHANG CX, Love MS, McNamara CW, Chi V, et al
    Pharmacokinetics and pharmacodynamics of clofazimine for treatment of cryptosporidiosis.
    Antimicrob Agents Chemother. 2021 Nov 8:AAC0156021. doi: 10.1128/AAC.01560.
    PubMed     Abstract available


  3. BOYER PL, Rehm CA, Sneller MC, Mican J, et al
    A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and C.
    Antimicrob Agents Chemother. 2021 Nov 1:AAC0150021. doi: 10.1128/AAC.01500.
    PubMed     Abstract available


    October 2021
  4. VAVRO C, Ruel T, Wiznia A, Montanez N, et al
    Emergence of Resistance in HIV-1 Integrase With Dolutegravir Treatment in a Pediatric Population From the IMPAACT P1093 Study.
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164521. doi: 10.1128/AAC.01645.
    PubMed     Abstract available


  5. UNDERWOOD M, Horton J, Nangle K, Hopking J, et al
    Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults With HIV-1 Infection Treated With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in the D
    Antimicrob Agents Chemother. 2021 Oct 25:AAC0164321. doi: 10.1128/AAC.01643.
    PubMed     Abstract available


  6. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
    Mutations in the HIV-1 3'-polypurine tract can confer dolutegravir resistance.
    Antimicrob Agents Chemother. 2021 Oct 11:AAC0102721. doi: 10.1128/AAC.01027.
    PubMed     Abstract available


    September 2021
  7. ASANTE-APPIAH E, Lai J, Wan H, Yang D, et al
    Impact of HIV-1 Resistance-associated Mutations on Susceptibility to Doravirine: Analysis of Real-world Clinical Isolates.
    Antimicrob Agents Chemother. 2021 Sep 27:AAC0121621. doi: 10.1128/AAC.01216.
    PubMed     Abstract available


  8. ABDELWAHAB MT, Wasserman S, Brust JCM, Dheda K, et al
    Linezolid population pharmacokinetics in South African adults with drug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2021 Sep 20:AAC0138121. doi: 10.1128/AAC.01381.
    PubMed     Abstract available


  9. ANKROM W, Jackson Rudd D, Schaeffer A, Panebianco D, et al
    Pharmacokinetic and Safety Profile of the Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor MK-8507 in Adults without HIV.
    Antimicrob Agents Chemother. 2021 Sep 13:AAC0093521. doi: 10.1128/AAC.00935.
    PubMed     Abstract available


  10. CILENTO ME, Reeve AB, Michailidis E, Ilina TV, et al
    Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA) Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor Resistant-Strains.
    Antimicrob Agents Chemother. 2021 Sep 13:AAC0116721. doi: 10.1128/AAC.01167.
    PubMed     Abstract available


  11. ZHOU CL, Huang YF, Li YB, Liang TZ, et al
    A new small-molecule compound, Q308, silences latent HIV-1 provirus by suppressing Tat- and FACT-mediated transcription.
    Antimicrob Agents Chemother. 2021 Sep 7:AAC0047021. doi: 10.1128/AAC.00470.
    PubMed     Abstract available


    August 2021
  12. SALAAM-DREYER Z, Streicher EM, Sirgel FA, Menardo F, et al
    Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa.
    Antimicrob Agents Chemother. 2021 Aug 30:AAC0036421. doi: 10.1128/AAC.00364.
    PubMed     Abstract available


  13. NGWALERO P, Brust JCM, van Beek SW, Wasserman S, et al
    Relationship between plasma and intracellular concentrations of bedaquiline and its M2 metabolite in South African patients with rifampin-resistant TB.
    Antimicrob Agents Chemother. 2021 Aug 9:AAC0239920. doi: 10.1128/AAC.02399.
    PubMed     Abstract available


  14. KULARATNE RS, Kufa T, Gumede L, Maseko DV, et al
    Demographic and behavioural risk factors associated with reduced susceptibility of Neisseria gonorrhoeae to first-line antimicrobials in South African men with gonococcal urethral discharge.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0038921. doi: 10.1128/AAC.00389.
    PubMed     Abstract available


    July 2021
  15. CHIA T, Nakamura T, Amano M, Takamune N, et al
    A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsid.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0103921. doi: 10.1128/AAC.01039.
    PubMed     Abstract available


    June 2021
  16. KA S, Merindol N, Sow AA, Singh A, et al
    Amaryllidaceae alkaloid cherylline inhibits the replication of dengue and Zika viruses.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0039821. doi: 10.1128/AAC.00398.
    PubMed     Abstract available


    May 2021
  17. WASSERMAN S, Davis A, Stek C, Chirehwa M, et al
    Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00140.
    PubMed     Abstract available


  18. NGUYEN NTQ, Gras E, Tran ND, Nguyen NNY, et al
    Pseudomonas aeruginosa Ventilator-Associated Pneumonia Rabbit Model for Preclinical Drug Development.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02724.
    PubMed     Abstract available


    April 2021
  19. MAO Y, Valour F, Nguyen NTQ, Doan TMN, et al
    Multi-mechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.01832.
    PubMed     Abstract available


  20. SUNDELL J, Wijk M, Bienvenu E, Abelo A, et al
    Factors affecting the pharmacokinetics of pyrazinamide and its metabolites in patients co-infected with HIV - implications for individualized dosing.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00046.
    PubMed     Abstract available


    March 2021
  21. SCHOLZ EMB, Mwangi JN, De la Cruz G, Nekorchuk M, et al
    Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, RT-SHIV RNA, and Collagen in the Mesenteric Lymph Nodes of Nonhuman Primates.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00019.
    PubMed     Abstract available


  22. PENE DUMITRESCU T, Joshi SR, Xu J, Zhan J, et al
    A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02173.
    PubMed     Abstract available


  23. WEI Y, Sluis-Cremer N
    Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand-Transfer Inhibitor Resistance.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02432.
    PubMed     Abstract available


  24. WHITE KL, Osman N, Cuadra-Foy E, Brenner BG, et al
    Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes.
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02406.
    PubMed     Abstract available


    February 2021
  25. BRUGGEMANS A, Vansant G, Balakrishnan M, Mitchell ML, et al
    GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02328.
    PubMed     Abstract available


  26. LODISE TP, Van Wart S, Sund ZM, Bressler AM, et al
    Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  27. MANDAL S, Prathipati PK, Sunagawa SW, Destache CJ, et al
    A new combination bictegravir+tenofovir alafenamide nanoformulation with prolonged sustained-drug-release potency for HIV-1 PrEP: A concept evaluation study.
    Antimicrob Agents Chemother. 2021 Feb 1. pii: AAC.02320.
    PubMed     Abstract available


    December 2020
  28. FERNANDEZ ML, Marson ME, Mastrantonio GE, Corti MA, et al
    BENZNIDAZOLE IN CEREBROSPINAL FLUID. A CASE SERIES OF CHAGAS DISEASE MENINGOENCEPHALITIS IN HIV POSITIVE PATIENTS.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01922.
    PubMed     Abstract available


  29. EKE AC, Shoji K, Best BM, Momper JD, et al
    Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women using Tenofovir Disoproxil Fumarate.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.02168.
    PubMed     Abstract available


  30. MARGOT N, Ram R, Rhee M, Callebaut C, et al
    Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
    Antimicrob Agents Chemother. 2020 Dec 7. pii: AAC.02057.
    PubMed     Abstract available


    November 2020
  31. KANE A, Campbell L, Ky D, Hibbs D, et al
    The antifungal and synergistic effect of bisphosphonates in Cryptococcus.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01753.
    PubMed     Abstract available


  32. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    PubMed     Abstract available


  33. ZUTZ A, Chen L, Sippl F, Humpe A, et al
    Epigenetic compound screening uncovers small molecules for re-activation of latent HIV-1.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01815.
    PubMed     Abstract available


    October 2020
  34. CALCAGNO A, Dal Conte I, Cattaneo D, Testi R, et al
    Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01902.
    PubMed     Abstract available


  35. WILLBY M, Chopra P, Lemmer D, Klein K, et al
    Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01663.
    PubMed     Abstract available


  36. BYRNE JM, Waack U, Weinstein EA, Joshi A, et al
    FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01983.
    PubMed     Abstract available


  37. WANG X, Mallikaarjun S, Gibiansky E
    Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multi-Drug Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01202.
    PubMed     Abstract available


  38. BARBEE LA, Soge OO, Ocbamichael N, LeClair A, et al
    A Single-arm Open-label Clinical Trial of 2g Aztreonam for the treatment of N. gonorrhoeae.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01739.
    PubMed     Abstract available


  39. ELDESOUKY HE, Salama EA, Lanman NA, Hazbun TR, et al
    Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.00684.
    PubMed     Abstract available


  40. BOWMAN ER, Cameron C, Richardson B, Kulkarni M, et al
    In vitro exposure of leukocytes to HIV pre-exposure prophylaxis (PrEP) decreases mitochondrial function and alters gene expression profiles.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01755.
    PubMed     Abstract available


  41. HUGHES E, Imperial M, Wallender E, Kajubi R, et al
    Piperaquine exposure is altered by pregnancy, HIV and nutritional status in Ugandan women.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01013.
    PubMed     Abstract available


  42. BENAMOR TEIXEIRA ML, Fuller TL, Fragoso da Silveira Gouvea MI, Santos Cruz ML, et al
    Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01068.
    PubMed     Abstract available


    June 2020
  43. PARSONS TL, Gwenden KN, Marzinke MA
    Inter-species Differences in Tenofovir Alafenamide Fumarate Stability in Plasma.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00930.
    PubMed     Abstract available


    February 2020
  44. EKE AC, Wang J, Amin K, Shapiro DE, et al
    Fosamprenavir with Ritonavir Pharmacokinetics During Pregnancy.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02260.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: